Evogene
evogene.comUses computational biology and generative AI to discover molecules and traits for agriculture and life-science products.
AIEstablished
About
Revolutionizing life-science product development utilizing cutting-edge computational biology technologies
Key facts
- Domain
- evogene.com
- Sector
- AI
- Language
- en-US
- Last checked
- 2026-10-29
Funding rounds (SEC Form D)
| Sale date | Issuer | Amount sold | Industry | Filing |
|---|---|---|---|---|
| 2026-02-11 | Evogene Ltd. | $3,384,616 | Pharmaceuticals | SEC |
Matched to this company by name. Source: SEC EDGAR Form D filings.
Links
Sources
- Company site: https://evogene.com/ (fetched 2026-10-29)
- SEC Form D: https://www.sec.gov/Archives/edgar/data/1574565/000117891326000573/0001178913-26-000573-index.htm
- LinkedIn: https://www.linkedin.com/company/evogene/
Data for this page: JSON ยท last checked 2026-10-29
Is this your company?
Claim the page with an email at your company domain, then fix facts and add what is missing. Free.
Claim this page